Anna Hirschberger
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune cells in cancer
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
-
- Immunotherapy and Immune Responses 2
- Immune Cell Function and Interaction 2
- Oncology 1
- Pancreatic and Hepatic Oncology Research 1
- Journals
- Nature (1 paper)Cancer Cell (1 paper)Blood (1 paper)Immunity (1 paper)Cell Reports (1 paper)
- Partner nations
- GermanySwitzerlandSpain
In The Last Decade
Anna Hirschberger
5 papers receiving 443 citations
Anna Hirschberger's Hit Papers
Peers
Comparison fields: 5 of 28
- Immunology 138
- Oncology 91
- Pharmacology 18
- Cancer Research 12
- Genetics 8
Countries citing papers authored by Anna Hirschberger
This map shows the geographic impact of Anna Hirschberger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Hirschberger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Hirschberger more than expected).
Fields of papers citing papers by Anna Hirschberger
This network shows the impact of papers produced by Anna Hirschberger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Hirschberger. The network helps show where Anna Hirschberger may publish in the future.
No co-authors to show.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A distinct stimulatory cDC1 subpopulation amplifies CD8+ T cell responses in tumors for protective anti-cancer immunity Hit paper breakdown → | 2023 | 154 |
| 2 | 2023 | 136 | |
| 3 | PGE2 limits effector expansion of tumour-infiltrating stem-like CD8+ T cells Hit paper breakdown → | 2024 | 135 |
| 4 | 2024 | 15 | |
| 5 | 2025 | 7 | |
| 6 | 2026 | 0 |
About Anna Hirschberger
Anna Hirschberger is a scholar working on Immunology, Oncology, Nuclear Energy and Engineering, Waste Management and Disposal and Infectious Diseases, having authored 6 papers that have together received 447 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (2 papers), Immune Cell Function and Interaction (2 papers) and Pancreatic and Hepatic Oncology Research (1 paper). The work is most often cited by research in Immunology (138 citations), Oncology (91 citations), Pharmacology (18 citations), Cancer Research (12 citations) and Genetics (8 citations). Anna Hirschberger has collaborated with scholars based in Germany, Switzerland and Spain. Their work appears in journals such as Nature, Cancer Cell, Blood, Immunity and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.